HC Wainwright & Co. Reiterates Buy on Applied DNA Sciences, Maintains $4 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a 'Buy' rating on Applied DNA Sciences (NASDAQ:APDN) and maintained a $4 price target.
August 24, 2023 | 10:23 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences has received a reiterated 'Buy' rating and a maintained $4 price target from HC Wainwright & Co.
The reiterated 'Buy' rating and maintained price target by HC Wainwright & Co. indicates a positive outlook for Applied DNA Sciences. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100